Pursuant to the Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indrayani Biotech has informed that it enclosed copy of newspaper publications pertaining to Unaudited Financial Results (Standalone and Consolidated) for the Quarter and half year ended September 30, 2025 published in Trinity Mirror in English Language and Makkal Kural in Tamil Language on December 13, 2025.
The above information is a part of company’s filings submitted to BSE.
